5
Triochem Products Ltd
TRIOCHEMPRODUCTSLTD NSE
Triochem Products Ltd
HealthcareNSE: TRIOCHEMPRODUCTSLTD BSE: TRIPR Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹0.00 Cr
Volatility
Low Risk
P/E Ratio
0
EBITDA
₹-1.39 Cr
Return on Equity
-2.93%
Debt to Equity
0
Book Value
₹478.88
EPS
₹0
52W High
₹0
52W Low
₹0
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Triochem Products Ltd insights
52 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -3.13% over last 3 years.
Growth Rate
Revenue Growth
-100.00% ↘
Net Income Growth
-2195.00% ↘
Cash Flow Change
105.32% ↗
ROE
-57.72% ↘
ROCE
-80.22% ↘
EBITDA Margin (Avg.)
-100.00% ↘
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.31 | 0.26 | 0.29 | 0.24 | 0.33 | 0.31 | 0.3 | 0.59 | 0.33 | 0.36 | 0.43 | 0.38 | 0.22 |
| Operating Profit | -0.31 | -0.26 | -0.29 | -0.24 | -0.33 | -0.31 | -0.3 | -0.59 | -0.33 | -0.36 | -0.43 | -0.38 | -0.22 |
| Other Income | 0.07 | 0.14 | -1.11 | 0.04 | 0.8 | 0.23 | 0.27 | 0.46 | 0.32 | 0.22 | 0.3 | 0.22 | 11.29 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 |
| Depreciation | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0 |
| PBT | -0.27 | -0.14 | -1.42 | -0.22 | 0.45 | -0.1 | -0.05 | -0.17 | -0.03 | -0.16 | -0.15 | -0.17 | 10.99 |
| Tax % | -25.93% | -21.43% | -27.46% | -4.55% | 28.89% | -20% | -20% | -147.06% | 1400% | -75% | 33.33% | -23.53% | 24.2% |
| Net Profit | -0.2 | -0.11 | -1.03 | -0.2 | 0.32 | -0.08 | -0.04 | 0.09 | -0.45 | -0.03 | -0.19 | -0.13 | 8.33 |
| EPS in Rs | -8.16 | -4.49 | -42.04 | -8.16 | 13.06 | -3.27 | -1.63 | 3.67 | -18.37 | -1.22 | -7.76 | -5.31 | 340 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.68 | 23.11 | 18.06 | 34.99 | 12.35 | 20.03 | 13.94 | 8.82 | 0 | 0 | 0 | 0 |
| Expenses | 29.44 | 22.11 | 17.07 | 31.18 | 10.71 | 15.48 | 14.3 | 7.47 | 1.33 | 1.05 | 1.22 | 1.39 |
| Operating Profit | 1.24 | 1 | 0.99 | 3.81 | 1.64 | 4.55 | -0.36 | 1.35 | -1.33 | -1.05 | -1.22 | -1.39 |
| OPM % | 4.04% | 4.33% | 5.48% | 10.89% | 13.28% | 22.72% | -2.58% | 15.31% | — | — | — | — |
| Other Income | 0.08 | -0.01 | 0.16 | 0.41 | 0.06 | 0.47 | 0.13 | 0.55 | 0.27 | -0.19 | 1.05 | 12.03 |
| Interest | 0.45 | 0.2 | 0.07 | 0.4 | 0.46 | 0.3 | 0.21 | 0.02 | 0 | 0 | 0 | 0.08 |
| Depreciation | 0.32 | 0.27 | 0.28 | 0.25 | 0.21 | 0.17 | 0.14 | 0.12 | 0.11 | 0.09 | 0.08 | 0.05 |
| PBT | 0.55 | 0.52 | 0.8 | 3.57 | 1.03 | 4.55 | -0.58 | 1.76 | -1.17 | -1.33 | -0.25 | 10.51 |
| Tax % | 23.64% | 32.69% | 28.75% | 28.57% | 29.13% | 25.27% | -24.14% | 25% | -24.79% | -24.06% | 60% | 24.17% |
| Net Profit | 0.42 | 0.34 | 0.58 | 2.56 | 0.74 | 3.4 | -0.45 | 1.32 | -0.89 | -1.01 | -0.4 | 7.97 |
| EPS in Rs | 17.14 | 13.88 | 23.67 | 104 | 30.2 | 139 | -18.37 | 53.88 | -36.33 | -41.22 | -16.33 | 325 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves | 4.31 | 4.65 | 5.24 | 7.79 | 8.53 | 11.93 | 11.47 | 12.8 | 11.35 | 14.38 | 13.42 | 20.4 |
| Borrowings | 3.5 | 0 | 2.86 | 2.28 | 5.79 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.42 | 2.12 | 1.93 | 1.47 | 0.58 | 1.94 | 0.38 | 0.28 | 0.24 | 0.25 | 0.23 | 0.23 |
| Total Liabilities | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
| Fixed Assets | 1.72 | 1.85 | 1.64 | 1.42 | 1.22 | 1.06 | 0.94 | 0.87 | 0.77 | 0.68 | 0.6 | 0 |
| CWIP | 0.37 | 0.04 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.12 | 3.68 | 0 | 0 | 0 | 0 | 0 | 0 | 9.42 | 11.07 | 10.63 | 7.89 |
| Other Assets | 6.27 | 1.45 | 8.64 | 10.37 | 13.93 | 15.53 | 11.13 | 12.46 | 1.65 | 3.13 | 2.67 | 12.99 |
| Total Assets | 8.48 | 7.02 | 10.28 | 11.79 | 15.15 | 16.62 | 12.1 | 13.33 | 11.84 | 14.88 | 13.9 | 20.88 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.34 | 6.79 | -6.48 | 1.45 | -3.75 | 3.82 | 10.25 | 3.47 | -1.03 | -3.76 | 0.2 | -2.87 |
| Investing | -0.1 | -3.7 | 3.71 | -0.01 | 0.02 | -0.03 | 0 | 0.16 | -9.82 | 3.34 | 0.17 | 13.7 |
| Financing | -1.69 | -3.68 | 2.8 | -0.92 | 3.06 | -3.49 | -2.61 | -0.02 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.56 | -0.59 | 0.03 | 0.52 | -0.67 | 0.3 | 7.64 | 3.61 | -10.85 | -0.42 | 0.37 | 10.82 |
| Free Cash Flow | 2.24 | 6.68 | -6.51 | 1.42 | -3.76 | 3.79 | 10.23 | 3.44 | -1.03 | -3.76 | 0.2 | 8.85 |
| CFO/OP | 241 | 682 | -635 | 56 | -176 | 106 | -2,939 | 287 | 105 | 351 | -17 | 63 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2.02 | 0 | 49.52 | 0 | 98.42 | 226 | 36.4 | 0 | — | — | — | — |
| Inventory Days | 55.65 | 5.85 | 52.93 | 104 | 414 | 41.57 | 24.6 | 2.9 | — | — | 0 | — |
| Days Payable | 1.45 | 31.02 | 36.57 | 9.13 | 14.72 | 19.85 | 9.26 | 9.85 | — | — | — | — |
| Cash Conversion Cycle | 56.22 | -25.17 | 65.88 | 95.24 | 498 | 248 | 51.74 | -6.95 | — | — | — | — |
| Working Capital Days | 16.06 | -19.43 | 63.06 | 56.23 | 217 | 191 | 63.1 | 0.83 | — | — | — | — |
| ROCE % | 11.78% | 11.57% | 12.83% | 42.53% | 11.97% | 33.16% | -2.8% | 14.45% | -10.14% | -2.67% | -3.32% | -3.38% |
Documents
1
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans
Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions
16 Apr - Quarterly default disclosure for 31 March 2026 shows nil debt and nil defaults. 16 Apr - Quarterly default disclosure for 31 March 2026 shows nil debt and nil defaults.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
16 Apr - Company confirms it is not a Large Corporate; initial disclosure for FY2026 not required. 16 Apr - Company confirms it is not a Large Corporate; initial disclosure for FY2026 not required.
3
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
16 Apr - Triochem Products says it is not a large corporate; no initial disclosure required for year ended March 31, 2026. 16 Apr - Triochem Products says it is not a large corporate; no initial disclosure required for year ended March 31, 2026.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
16 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. 16 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
Frequently Asked Questions about Triochem Products Ltd
What does Triochem Products Ltd do?
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
Where is Triochem Products Ltd (512101) listed?
Triochem Products Ltd is listed on the Indian stock exchanges. It is listed on NSE: TRIOCHEMPRODUCTSLTD and BSE: TRIPR. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Triochem Products Ltd belong to?
Triochem Products Ltd operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Triochem Products Ltd?
Triochem Products Ltd has a market capitalisation of approximately ₹0. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Triochem Products Ltd?
The Price-to-Earnings (PE) ratio of Triochem Products Ltd is 0.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Triochem Products Ltd?
Over the past 52 weeks, Triochem Products Ltd has traded between a low of ₹0 and a high of ₹0. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Triochem Products Ltd?
Triochem Products Ltd has a Return on Equity (ROE) of -2.93%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Triochem Products Ltd on Tapetide?
On Tapetide, you can view Triochem Products Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.